Clinical TrialsSearch results
Number of results: 823
Other
- Phase II study of S-1 in patients with gemcitabine-refractory advanced biliary tract cancer
- Patients with gemcitabine-refractory advanced biliary tract cancer
- National Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division
- 2007-12-01
Other
- Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
- Multiple myeloma expressing CD20
- Zenyaku Kogyo Co., Ltd.
- 2006-11-28
Other
- Phase II study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- Phase II study of rituximab in patients with severe systemic lupus erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy in treating pediatric patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumors
- medulloblastoma or supratentorial primitive neuroectodermal tumors
- Japanese Pediatric Brain Tumor Consortium
- 2006-12-08
Other
- Phase II study of pre-emptive therapy against CMV-associated disesase by valganciclovir after allogeneic hematopoietic stem cell transplantation
- Patients with CMV reactivation after allogeneic hematopoietic stem cell transplantation
- Dept of 1st Intern Med, Kyushu Univ Hospital
- 2008-04-01
Other
- Phase II study of neoadjuvant treatment with Exemestane for 24 weeks in postmenopausal women with hormone receptor positive Stage II or IIIA breast cancer.
- Breast Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-03-06
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Phase II study of Irinotecan, TS-1 and Bevacizumab as second-line treatment in patients with advanced colorectal cancer (KMOG 0708)
- advanced colorectal cancer
- Kyushu Medical Oncology Group
- 2009-03-26
Other
- phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive disease small-cell lung cancer.
- extensive disease small-cell lung cancer
- West Japan Oncology Group
- 2005-09-05